Nephrology
Research and innovation from the nephrology experts at Vanderbilt Health
Which Antibiotics to Choose for Hospital Infection?
Cefepime raised neurotoxicity risk; piperacillin-tazobactam did not raise risk to kidneys as previously thought.
Read MoreLatest in Nephrology
Transplant Excellence Result of Skill, Innovation and Teamwork
Vanderbilt surpasses its previous annual record for solid organ transplants, establishing it as the fifth-largest transplant center in the nation.
Inflammation Factors in Obesity and Kidney Injury
Studies connect receptor pathways to macrophages and inflammation in both obesity and kidney fibrosis.
Exceptional Growth for Amyloidosis Care
Vanderbilt soars with emerging therapeutics and is the first dedicated amyloidosis treatment center in Tennessee.
Partners in Care
Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.
Make a ReferralAPOL1 Tied to Higher COVID-19 Mortality
Nationwide analysis finds variants may confer more than elevated risk of kidney disease.
How Bacteria Battles Acidity to Cause UTIs
A novel mechanism of acid resistance expands E. coli’s defenses and may guide researchers toward better treatment for a common infection.
Mutated DNA Regulator Implicated in Cancer Cell Development
Studies on SETD2 identified correlations between mutated chromosomes in cancer cells and chemotherapy resistance.
Unexpected Consequences of Rac1 Protein
Research provides insight into how these key proteins support kidney ducts’ cellular integrity.
Magnesium’s Role in Salt-Sensitive Hypertension
Mouse model investigation confirms link between magnesium and blood pressure response.
Disparities Emerge, From Evaluation to Transplant
Research shows varying levels of disparities throughout the kidney transplant process.